Navigation Links
Fertility drug usage and cancer risk
Date:7/6/2012

Women using fertility drugs who did not conceive a 10-plus week pregnancy were at a statistically significant reduced risk of breast cancer compared to nonusers; however, women using the drugs who conceived a 10-plus week pregnancy had a statistically significant increased risk of breast cancer compared to unsuccessfully treated women, but a comparable risk to nonusers, according to a study published July 6 in the Journal of The National Cancer Institute.

Ovulation-stimulating fertility drugs temporarily elevate estrogen levels in women, and estrogen is known to play an important role in breast cancer. While some studies report increased breast cancer risk following infertility treatment, other analyses have been inconclusive.

In order to determine the risk of young-onset breast cancer after use of ovulation-stimulating fertility drugs, Chunyuan Fei, Ph.D., at the National Institute of Environmental Health Sciences (NIEHS), and colleagues, conducted a sister-matched case-control study, in part funded by Susan Komen for the Cure, called the Two Sister Study (which was developed from the Sister Study), which looked at women diagnosed with breast cancer under the age of 50 years and their breast cancer-free control sisters, who were studied between September 2008-December 2010. They looked specifically at fertility-drug exposure according to whether or not it had resulted in a pregnancy lasting at least 10 weeks.

The researchers found that women who had used fertility drugs showed a non-statistically significantly reduced risk of breast cancer compared to women who did not use fertility drugs and women who used fertility drugs and did not conceive a 10-plus week pregnancy were at a statistically significantly lowered risk of breast cancer compared to nonusers. Women who had used fertility drugs and conceived a 10-plus week pregnancy did, however, have a statistically significantly increased risk of breast cancer compared to wom
'/>"/>

Contact: Kristine Crane
Kristine.crane@oup.com
301-841-1287
Journal of the National Cancer Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Can Fertility Treatments Influence Later Breast Cancer Risk?
2. Fertility preservation with cryopreservation of ovarian tissue: from experimental to mainstream
3. Heavy Coffee Intake May Affect Fertility Treatments: Study
4. Childless women with fertility problems at higher risk of hospitalization for psychiatric disorders
5. Success of fertility treatment may approach natural birth rate
6. Under Right Conditions, Fertility Treatment Can Equal Natural Conception Rates: Study
7. Could Fertility Drugs Make Kids Shorter?
8. Men and Women With Cancer May Receive Different Fertility Information
9. Men and women receive different fertility advice following cancer diagnosis
10. Scientists develop mouse model that could lead to new therapies for liver cancer
11. Worlds fastest camera, created by UCLA engineers, used to detect rogue cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 AmeriPride Services, a leading ... announced the launch of its new Customer Portal, an ... easier and more convenient for customers. The industry-leading digital ... better communicate with the company. , Features of the ... Access, download and pay bills online , ...
(Date:8/28/2014)... 2014 Clarity PSO , an ... as a federal Patient Safety Organization (PSO) for another ... Healthcare Research and Quality (AHRQ). Clarity PSO will continue ... services following the true intentions of the Patient Safety ... are proud and eager to continue our journey as ...
(Date:8/28/2014)... 2014 Genetic testing for multiple ... world, with large reference laboratories as well as ... with regard to the genetic variants analyzed, the ... struggle to find the most appropriate laboratory providers ... sort through these differences, Hayes, Inc. has added ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 veEDIS ... Emergency Department Information System (EDIS), in Lawrence Medical ... nurses and physicians to document patient care, veEDIS ... patient record-keeping, as well as the authorized, confidential ... Through the veEDIS technology, designed in accordance ...
(Date:8/28/2014)... Altec Products, Inc., a leader ... today that they have been awarded the “Partnering ... the International Association of Microsoft Channel Partners (IAMCP) ... in 1994, providing Microsoft Partners with a voice ... at large while facilitating mutual growth and business ...
Breaking Medicine News(10 mins):Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Hayes, Inc. Unveils Laboratory Comparison Tables for GTE Clients 2Health News:veEDIS Clinical Systems “Delivers,” as the 2014 Edition CEHRT Emergency Department EHR System is Implemented at Lawrence Medical Center 2Health News:veEDIS Clinical Systems “Delivers,” as the 2014 Edition CEHRT Emergency Department EHR System is Implemented at Lawrence Medical Center 3Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 3
... of patients whose myelodysplastic syndrome is related to earlier ... have a poor prognosis, researchers from The University of ... Annual Meeting of the American Society of Hematology. ... or both treatments are usually told that they have ...
... of biological macromolecules are the central bases of ... cells by linking many small molecules together. Naturally ... A detailed understanding of the synthesis of these ... for understanding biological systems, and for the development ...
... smells apart is no problem for the human nose. How ... by an interdisciplinary team of researchers at the RUB. The ... of the three-dimensional structure of the binding site of an ... pattern of hydrogen bonds between odorant and receptor, which accounts ...
... News) -- Undiagnosed chronic fatigue syndrome may account for up ... for extended periods of time and are not truant or ... out of school, a new study reveals. For the ... 16 at three secondary schools in England and concluded that ...
... US Prostate Cancer Prevention Trial found cancer in many men ... which PSA level should lead to a biopsy recommendation. ... considerable controversy, that the evidence does not support recommending PSA ... the risks outweigh the benefits. Now, a study shows ...
... - Adding a drug that activates genes to frontline combination ... remission rate after initial treatment, researchers at The University of ... Meeting of the American Society of Hematology. Results of ... stage for a national Phase III clinical trial of the ...
Cached Medicine News:Health News:Prognostic model developed for MDS related to prior cancer therapy 2Health News:Prognostic model developed for MDS related to prior cancer therapy 3Health News:Visualization of DNA synthesis in vivo 2Health News:A good nose: RUB-Researchers decipher interaction of fragrances and olfactory receptors 2Health News:Chronic Fatigue Tied to Extended School Absences 2Health News:Biopsy referral after PSA screening stays consistent over time 2Health News:AML patients have high response rate with vorinostat added to treatment 2
(Date:8/28/2014)... Ohio , Aug. 28, 2014  A ... competition in generics are adding pressure to pharmaceutical, ... resources. Company resources continue to shrink and approval ... This has led companies to look for additional ... commercialization and for keeping approved products on the ...
(Date:8/28/2014)... VIEJO , Kalifornien, 28. August ... hat heute den Start der Patientenrekrutierung ... Device Exemption, Forschungsausnahmegenehmigung) zur Beurteilung der ... zur Embolisation von Aneurysmen („WEB") bekanntgegeben. Adam ... of Tennessee, Department of Neurosurgery/Semmes-Murphey Clinic, ...
(Date:8/28/2014)... , Aug. 28, 2014  Sequent Medical, ... enrollment in an Investigational Device Exemption ("IDE") pivotal ... the WEB™ Aneurysm Embolization System ("WEB"). Adam ... Department of Neurosurgery/Semmes-Murphey Clinic and Principal Investigator of ... the study, treating them with the WEB at ...
Breaking Medicine Technology:4 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 24 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 34 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 4Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 2Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 3Sequent Medical Announces Initiation Of IDE Study For The WEB Aneurysm Embolization System 2Sequent Medical Announces Initiation Of IDE Study For The WEB Aneurysm Embolization System 3
... Medical International Limited (NYSE: MR ), a leading ... its selected unaudited financial results for the first quarter ended ... First Quarter 2011 Net revenues were $180.9 ... 2010. Robust international sales of $108.5 million, a year-over-year ...
... /PRNewswire-Asia/ -- Chindex International, Inc. (NASDAQ: ... services in China through the operations of United Family Healthcare, ... clinics, today announced financial results for the three month period ... 2011 Financial Highlights Revenue from healthcare ...
Cached Medicine Technology:Mindray Announces First Quarter 2011 Financial Results 2Mindray Announces First Quarter 2011 Financial Results 3Mindray Announces First Quarter 2011 Financial Results 4Mindray Announces First Quarter 2011 Financial Results 5Mindray Announces First Quarter 2011 Financial Results 6Mindray Announces First Quarter 2011 Financial Results 7Mindray Announces First Quarter 2011 Financial Results 8Mindray Announces First Quarter 2011 Financial Results 9Mindray Announces First Quarter 2011 Financial Results 10Mindray Announces First Quarter 2011 Financial Results 11Mindray Announces First Quarter 2011 Financial Results 12Mindray Announces First Quarter 2011 Financial Results 13Mindray Announces First Quarter 2011 Financial Results 14Chindex International, Inc. Reports First Quarter 2011 Financial Results 2Chindex International, Inc. Reports First Quarter 2011 Financial Results 3Chindex International, Inc. Reports First Quarter 2011 Financial Results 4Chindex International, Inc. Reports First Quarter 2011 Financial Results 5Chindex International, Inc. Reports First Quarter 2011 Financial Results 6Chindex International, Inc. Reports First Quarter 2011 Financial Results 7Chindex International, Inc. Reports First Quarter 2011 Financial Results 8Chindex International, Inc. Reports First Quarter 2011 Financial Results 9Chindex International, Inc. Reports First Quarter 2011 Financial Results 10
HbA1c / HbCalibrator...
Heparin-Platelet Factor 4 Induced Antibody...
Multi-constituent Calibration Plasma for Functional Assays of Coagulation Parameters on STA© Analyzers....
Control Plasma for Assays of Unfractionated Heparins (UH) using Anti-Xa Methodon STA© Analyzers....
Medicine Products: